Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says

RSV vac­cine man­u­fac­tur­ers Sanofi and As­traZeneca will make 230,000 more dos­es of their im­mu­niza­tions for in­fants avail­able be­gin­ning in Jan­u­ary to ad­dress high de­mand, the White House an­nounced Thurs­day.

The an­nounce­ment comes as Biden ad­min­is­tra­tion of­fi­cials met with vac­cine man­u­fac­tur­ers on Wednes­day to dis­cuss ramp­ing up RSV im­mu­niza­tion op­tions for chil­dren this fall as man­u­fac­tur­ers face high­er de­mand than an­tic­i­pat­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.